These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 759246

  • 21. [Etiopathogenetic role of metabolic, circulatory, sex factors and type and duration of diabetes in diabetic retinopathy. Investigation with vitreofluorophotometry].
    Arsenio L, Dall'Aglio E, Magnati G, Nuzzi G, Bonacini M, Venturini I, Ferretti G, Gelmini G, Passeri M, Strata A.
    G Clin Med; 1989 May; 70(5):341-51. PubMed ID: 2666226
    [Abstract] [Full Text] [Related]

  • 22. Antihistamines reduce blood-retinal barrier permeability in type I (insulin-dependent) diabetic patients with nonproliferative retinopathy. A pilot study.
    Gardner TW, Eller AW, Friberg TR, D'Antonio JA, Hollis TM.
    Retina; 1995 May; 15(2):134-40. PubMed ID: 7624601
    [Abstract] [Full Text] [Related]

  • 23. [Fluorophotometric study of juvenile insulin-dependent diabetic patients].
    Domosławski M, Skopiński P, Trippenbach H.
    Klin Oczna; 1998 May; 100(6):369-71. PubMed ID: 10067063
    [Abstract] [Full Text] [Related]

  • 24. [Follow-up of early diabetic maculopathy by angiography and fluorophotometry].
    Cunha-Vaz J, Faria de Abreu JR, Leite E, Mira JB.
    J Fr Ophtalmol; 1989 May; 12(10):657-9. PubMed ID: 2638361
    [Abstract] [Full Text] [Related]

  • 25. Vitreous fluorophotometry in juvenile-onset diabetes mellitus.
    Krupin T, Waltman SR, Oestrich C, Santiago J, Ratzan S, Kilo C, Becker B.
    Arch Ophthalmol; 1978 May; 96(5):812-4. PubMed ID: 655917
    [Abstract] [Full Text] [Related]

  • 26. Vitreous fluorophotometry: identification of sources of variability.
    Prager TC, Wilson DJ, Avery GD, Merritt JH, Garcia CA, Hopen G, Anderson RE.
    Invest Ophthalmol Vis Sci; 1981 Dec; 21(6):854-64. PubMed ID: 7309436
    [Abstract] [Full Text] [Related]

  • 27. Fluorophotometry in juvenile-onset diabetes: long-term follow-up.
    Krupin T, Waltman SR.
    Jpn J Ophthalmol; 1985 Dec; 29(2):139-45. PubMed ID: 4046222
    [Abstract] [Full Text] [Related]

  • 28. Early breakdown of the blood-retinal barrier in diabetes.
    Cunha-Vaz J, Faria de Abreu JR, Campos AJ.
    Br J Ophthalmol; 1975 Nov; 59(11):649-56. PubMed ID: 1203221
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Short-term effects of intravitreal triamcinolone on retinal vascular leakage and trunk vessel diameters in diabetic macular oedema.
    Vinten M, Larsen M, Lund-Andersen H, Sander B, La Cour M.
    Acta Ophthalmol Scand; 2007 Feb; 85(1):21-6. PubMed ID: 17244205
    [Abstract] [Full Text] [Related]

  • 31. Ocular fluorophotometry in diabetic patients without apparent retinopathy.
    Kayazawa F.
    Ann Ophthalmol; 1984 Mar; 16(3):221-5. PubMed ID: 6712065
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Permeability of the blood-retinal barrier and the blood-aqueous barrier in type I diabetes without diabetic retinopathy: simultaneous evaluation with fluorophotometry.
    Schalnus R, Ohrloff C, Jungmann E, Maass K, Rinke S, Wagner A.
    Ger J Ophthalmol; 1993 Aug; 2(4-5):202-6. PubMed ID: 8220099
    [Abstract] [Full Text] [Related]

  • 34. Quantitative vitreous fluorophotometry applying a mathematical model of the eye.
    Lund-Andersen H, Krogsaa B, la Cour M, Larsen J.
    Invest Ophthalmol Vis Sci; 1985 May; 26(5):698-710. PubMed ID: 3997419
    [Abstract] [Full Text] [Related]

  • 35. Increased vitreous levels of hydroimidazolone in type 2 diabetes patients are associated with retinopathy: a case-control study.
    Fosmark DS, Bragadóttir R, Stene-Johansen I, Berg JP, Berg TJ, Lund T, Sandvik L, Hanssen KF.
    Acta Ophthalmol Scand; 2007 Sep; 85(6):618-22. PubMed ID: 17488318
    [Abstract] [Full Text] [Related]

  • 36. [Fluorophotometry of the vitreous body in insulin-dependent diabetes mellitus with minimal retinopathy or without it].
    Roy MS, Podgor MJ, Grunberger G, Carl J, Bungay P, Ellis D.
    Ophtalmologie; 1987 Sep; 1(2):151-4. PubMed ID: 3153837
    [No Abstract] [Full Text] [Related]

  • 37. Vitreous fluorophotometry in patients with no or minimal diabetic retinopathy.
    Chahal P, Fallon TJ, Jennings SJ, Chowienczyk PJ, Kohner EM.
    Diabetes Care; 1986 Sep; 9(2):134-9. PubMed ID: 3698779
    [Abstract] [Full Text] [Related]

  • 38. Vitreous fluorophotometry and retinal blood flow studies in proliferative retinopathy.
    Cunha-Vaz JG, Fonseca JR, Abreu JF.
    Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1978 Jul 17; 207(2):71-6. PubMed ID: 308782
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Vitreous fluorophotometry in diabetes with normal fundi].
    Kayazawa F, Tsuji T, Matsuda T, Kuwayama W, Machida T.
    Nippon Ganka Gakkai Zasshi; 1983 Jul 17; 87(8):595-601. PubMed ID: 6637676
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.